<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(24)</volume><submitter>Szymczak M</submitter><funding>Wroclaw Medical University</funding><journal>Journal of clinical medicine</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11679591</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Influence of Anti-ETAR and Anti-CXCR3 Antibody Levels on the Course of Specific Glomerulonephritis Types</pubmed_title><pmcid>PMC11679591</pmcid><funding_grant_id>SUBZ.C160.24.090</funding_grant_id><pubmed_authors>Banasik M</pubmed_authors><pubmed_authors>Bukowiec-Marek K</pubmed_authors><pubmed_authors>Gołebiowski T</pubmed_authors><pubmed_authors>Schulze-Forster K</pubmed_authors><pubmed_authors>Konieczny A</pubmed_authors><pubmed_authors>Kujawa K</pubmed_authors><pubmed_authors>Heidecke H</pubmed_authors><pubmed_authors>Zabinska M</pubmed_authors><pubmed_authors>Wronowicz J</pubmed_authors><pubmed_authors>Janek Ł</pubmed_authors><pubmed_authors>Szymczak M</pubmed_authors><pubmed_authors>Skalec K</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Influence of Anti-ETAR and Anti-CXCR3 Antibody Levels on the Course of Specific Glomerulonephritis Types</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-04T02:22:38.909Z</modification><creation>2025-04-04T02:22:38.909Z</creation></dates><accession>S-EPMC11679591</accession><cross_references/></HashMap>